Cargando…

Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses

BACKGROUND: Stress-induced post-translational modifications occur during autophagy and can result in generation of new epitopes and immune recognition. One such modification is the conversion of arginine to citrulline by peptidylarginine deiminase enzymes. METHODS: We used Human leukocyte antigen (H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brentville, Victoria A, Metheringham, Rachael L, Daniels, Ian, Atabani, Suha, Symonds, Peter, Cook, Katherine W, Vankemmelbeke, Mireille, Choudhury, Ruhul, Vaghela, Poonam, Gijon, Mohamed, Meiners, Ghislaine, Krebber, Willem-Jan, Melief, Cornelis J M, Durrant, Lindy G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Clinical/Translational Cancer Immunotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304843/ https://www.ncbi.nlm.nih.gov/pubmed/32561639 http://dx.doi.org/10.1136/jitc-2020-000560

Ejemplares similares

Citrullinated α-enolase is an effective target for anti-cancer immunity
por: Cook, Katherine, et al.
Publicado: (2017)

Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy
por: Cook, Katherine W, et al.
Publicado: (2021)

T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapy
por: Brentville, Victoria A, et al.
Publicado: (2019)

PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy
por: Choudhury, Ruhul H, et al.
Publicado: (2022)

Vaccine Can Induce CD4-Mediated Responses to Homocitrullinated Peptides via Multiple HLA-Types and Confer Anti-Tumor Immunity
por: Cook, Katherine, et al.
Publicado: (2022)

Citrullinated Epitopes Identified on Tumour MHC Class II by Peptide Elution Stimulate Both Regulatory and Th1 Responses and Require Careful Selection for Optimal Anti-Tumour Responses
por: Symonds, Peter, et al.
Publicado: (2021)

Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy
por: Brentville, Victoria Anne, et al.
Publicado: (2022)

High Avidity Cytotoxic T Lymphocytes Can Be Selected into the Memory Pool but They Are Exquisitely Sensitive to Functional Impairment
por: Brentville, Victoria A., et al.
Publicado: (2012)

SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors
por: Xue, Wei, et al.
Publicado: (2016)

SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade
por: Xue, Wei, et al.
Publicado: (2016)

Cancer cell associated glycans as targets for immunotherapy
por: Vankemmelbeke, Mireille, et al.
Publicado: (2015)

Cancer Vaccines, Adjuvants, and Delivery Systems
por: Paston, Samantha J., et al.
Publicado: (2021)

The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis
por: Van Steendam, Katleen, et al.
Publicado: (2011)

Citrullinated α enolase, a novel citrullinated autoantigen in rheumatoid arthritis, upregulated by chronic inflammation
por: Kinloch, A, et al.
Publicado: (2005)

The rheumatoid arthritis specific Sa antigen is citrullinated vimentin
por: Vossenaar, ER, et al.
Publicado: (2004)

Evaluation of autoantibodies against vimentin and α-enolase in rheumatoid arthritis patients
por: Ebrahimi-Rad, Mina, et al.
Publicado: (2020)

A Novel HAGE/WT1-ImmunoBody(®) Vaccine Combination Enhances Anti-Tumour Responses When Compared to Either Vaccine Alone
por: Almshayakhchi, Rukaia, et al.
Publicado: (2021)

Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA)
por: Ruiz-Ortiz de Arrizabaleta, Estíbaliz, et al.
Publicado: (2011)

Identification of citrullinated α-enolase as a candidate autoantigen in rheumatoid arthritis
por: Kinloch, Andrew, et al.
Publicado: (2005)

Specificity of Anti-Citrullinated Protein Antibodies to Citrullinated α-Enolase Peptides as a Function of Epitope Structure and Composition
por: Fanelli, Ilaria, et al.
Publicado: (2021)

Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial
por: Patel, Poulam M., et al.
Publicado: (2018)

Current Strategies to Enhance Anti-Tumour Immunity
por: Cook, Katherine W., et al.
Publicado: (2018)

Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis
por: Gilliam, Brooke E, et al.
Publicado: (2013)

Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
por: Vossenaar, Erik R, et al.
Publicado: (2004)

The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
por: Guseinova, D, et al.
Publicado: (2008)

Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
por: Dejaco, Christian, et al.
Publicado: (2006)

Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins
por: Van Steendam, Katleen, et al.
Publicado: (2010)

Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies
por: Reed, Evan, et al.
Publicado: (2016)

Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
por: Al-Shukaili, Ahmed, et al.
Publicado: (2012)

Pattern of drugs use and association with anti-mutated citrullinated vimentin antibody in rheumatoid arthritis
por: Safi, Mohammad-Ayman A., et al.
Publicado: (2015)

The Relationship of Antibodies to Modified Citrullinated Vimentin and Markers of Bone and Cartilage Destruction in Rheumatoid Arthritis
por: Avdeeva, A. S., et al.
Publicado: (2014)

Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vimentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis
por: Gonzalez-Lopez, Laura, et al.
Publicado: (2014)

Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study
por: Ursum, Jennie, et al.
Publicado: (2008)

Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
por: Abdeen, Suad, et al.
Publicado: (2011)

Association of levels of antibodies against citrullinated cyclic peptides and citrullinated α-enolase in chronic and aggressive periodontitis as a risk factor of Rheumatoid arthritis: a case control study
por: Reichert, Stefan, et al.
Publicado: (2015)

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
por: Nicaise Roland, Pascale, et al.
Publicado: (2008)

Antibodies to Mutated Citrullinated Vimentin in Rheumatoid Arthritis: Diagnostic Value, Association with Radiological Damage and Axial Skeleton Affection
por: Mansour, Howaida E., et al.
Publicado: (2010)

Higher Levels of Autoantibodies Targeting Mutated Citrullinated Vimentin in Patients with Psoriatic Arthritis Than in Patients with Psoriasis Vulgaris
por: Dalmády, Szandra, et al.
Publicado: (2013)

Extracellular Release of Citrullinated Vimentin Directly Acts on Osteoclasts to Promote Bone Resorption in a Mouse Model of Periodontitis
por: Shindo, Satoru, et al.
Publicado: (2023)

Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity
por: Shah, Sabaria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pp31iure74cusea4tkdebfrgvr